放射腫瘤學市場規模、佔有率和成長分析（按類型、應用、最終用戶、地區）：產業預測（2024-2031）

Radiation Oncology Market Size, Share, Growth Analysis, By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Application (Prostate Cancer, Breast Cancer), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月10日 | 出版商:

SkyQuest | 英文 172 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球放射腫瘤學（癌症放射治療）市場規模估值為83.4億美元，從2023年的93.7億美元成長到2031年的237億美元，在預測期內預計將以12.3%的複合年成長率成長（ 2024-2031）。

由於人口老化、生活方式改變和環境影響等因素，癌症盛行率不斷上升，推動全球放射腫瘤學市場強勁成長。據世界衛生組織 (WHO) 稱，2022 年全球將有約 1,930 萬人被診斷出患有癌症，約 1,000 萬人將死亡，歐洲將報告 460 萬新病例。強度調控放射治療放射線手術(SRS) 等放射治療技術的進步正在提高治療精度並改善患者治療效果，進一步推動市場擴張。例如，Acure Incorporated 的 Tomo C 放射治療系統最近在中國獲得批准，這是其成長策略的一個重要里程碑。此外，PharmLogic Holdings Corp. 已簽訂一項基礎服務協議，開發針對轉移性黑色素瘤和神經內分泌癌的治療診斷候選藥物，為該市場提供持續支持，這表明了技術創新。隨著對有效放射腫瘤學的需求持續上升，市場格局將持續發展，使其成為醫療產業研究、開發和投資的重點。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 波灣合作理事會(GCC) 國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

瓦里安醫療系統公司（Siemens Healthineers AG）（美國）
醫科達公司（瑞典）
Accuray公司（美國）
IBA Radiopharma Solutions（比利時）
BD（貝克頓迪金森公司）（美國）
艾索瑞公司（美國）
Mevion 醫療系統（美國）
Nordion, Inc. (Sotera Health)（加拿大）
NTP 放射性同位素 SOC Ltd.（南非）
鋦（法國）
ViewRay 科技公司（美國）
IBA 全球（比利時）
提供醫療保健（美國）
佳能公司（日本）
日立有限公司（日本）
Icad 公司（美國）
離子束應用（比利時）
Panacea 醫療科技私人有限公司（印度）
P-Cure 有限公司（以色列）

簡介目錄

Product Code: SQMIG35A2944

Global Radiation Oncology Market size was valued at USD 8.34 billion in 2022 and is poised to grow from USD 9.37 billion in 2023 to USD 23.70 billion by 2031, growing at a CAGR of 12.3% in the forecast period (2024-2031).

The global radiation oncology market is experiencing robust growth, driven by the rising prevalence of cancer, attributed to factors such as an aging population, lifestyle changes, and environmental influences. According to the World Health Organization (WHO), approximately 19.3 million people were diagnosed with cancer worldwide in 2022, resulting in around 10 million deaths, with significant incidences noted in Europe, where 4.6 million new cases were reported. The advancements in radiation therapy technologies, such as intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery (SRS), are enhancing treatment accuracy and improving patient outcomes, further propelling market expansion. Key players in the industry are actively pursuing strategies to bolster their presence; for instance, Acure Incorporated recently received regulatory approval for its Tomo C radiation therapy system in China, marking a significant milestone in its growth strategy. Additionally, PharmLogic Holdings Corp. has entered a master services agreement to develop theranostic candidates targeting metastatic melanoma and neuroendocrine cancer, showcasing ongoing innovation within the market. As the demand for effective cancer treatments continues to rise, the radiation oncology market is poised for continued development, making it an essential focus area for research and investment in the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiation Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiation Oncology Market Segmental Analysis

Global Radiation Oncology Market is segmented on the type, application, end user, and region. By type, market is segmented into External Beam Radiation Therapy, and Internal Beam Radiation Therapy. By application, market is segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, and Others. By end user, market is segmented into Hospitals, Specialty Clinics, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Radiation Oncology Market

The surge in global cancer incidence serves as a primary catalyst for the growth of the radiation oncology market. With cancer ranking as one of the foremost causes of mortality across diverse demographics, there is an escalating demand for advanced treatment modalities, particularly radiation therapy. This heightened need prompts substantial investments in innovative radiation technologies and oncology solutions, facilitating enhanced patient outcomes and expanding market accessibility. Additionally, ongoing research and development efforts aim to improve treatment efficacy and minimize side effects, thereby driving the adoption of radiation oncology in clinical settings. Together, these factors collectively bolster the expansion of the global radiation oncology market.

Restraints in the Global Radiation Oncology Market

The Global Radiation Oncology market faces significant restraints due to the prohibitive costs associated with radiation therapy and its advanced equipment. High investment requirements for sophisticated technologies, such as linear accelerators and imaging systems, can be a barrier for numerous healthcare providers, particularly in low- and middle-income countries where budget constraints are prevalent. This financial burden limits the availability of essential radiation treatment services, restricting access for patients and dampening overall market penetration. Consequently, the inability to implement cutting-edge radiation oncology solutions in underserved regions stifles market expansion and inhibits the adoption of potentially life-saving cancer therapies.

Market Trends of the Global Radiation Oncology Market

The Global Radiation Oncology market is witnessing a significant trend towards the increasing adoption of proton therapy, characterized by its enhanced precision in targeting tumors while minimizing damage to adjacent healthy tissues. This advanced treatment modality is becoming increasingly recognized for its efficacy, particularly in treating complex cancers, fostering greater patient outcomes. As awareness rises and technological advancements reduce costs, demand for proton therapy is anticipated to surge, subsequently catalyzing growth and innovation throughout the radiation oncology sector. Consequently, this trend not only reflects a shift in clinical practices but also indicates a broader commitment to personalized cancer care solutions in the healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
PESTEL Analysis
Technology Analysis
Regulatory Analysis
Market Attractiveness Index, 2023
Case Study Analysis

Radiation Oncology Market, By Type

Market Overview
External Beam Radiation Therapy
- Conformal Radiation Therapy
- Proton Beam Therapy
- Image-guided Radiation Therapy
- Stereotactic Radiation Therapy
- Others
Internal Beam Radiation Therapy
- Brachytherapy
- Systemic Beam Radiation Therapy
- Others

Radiation Oncology Market, By Application

Market Overview
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Gynecological Cancer
Cervical Cancer
Penile Cancer
Others

Radiation Oncology Market, By End User

Market Overview
Hospitals
Specialty Clinics
Others

Radiation Oncology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Varian Medical Systems, Inc. (Siemens Healthineers AG) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Radiopharma Solutions (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isoray Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mevion Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion, Inc. (Sotera Health) (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NTP Radioisotopes SOC Ltd. (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViewRay Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Worldwide (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Provision Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icad Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ion Beam Applications (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Medical Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
P-Cure Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments